Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pre-Eclampsia | 4 | 2021 | 599 | 1.15 | Why? |
| Delivery, Obstetric | 4 | 2020 | 1292 | 0.97 | Why? |
| Labor, Induced | 2 | 2020 | 186 | 0.88 | Why? |
| Pregnancy Complications, Infectious | 10 | 2021 | 11559 | 0.87 | Why? |
| Hospitals, Maternity | 2 | 2020 | 154 | 0.83 | Why? |
| Pregnancy | 27 | 2021 | 23879 | 0.77 | Why? |
| DNA Copy Number Variations | 1 | 2018 | 84 | 0.74 | Why? |
| Pregnancy Trimesters | 1 | 2018 | 90 | 0.72 | Why? |
| Maternal Age | 1 | 2018 | 244 | 0.69 | Why? |
| Adiponectin | 1 | 2018 | 123 | 0.67 | Why? |
| DNA, Mitochondrial | 1 | 2018 | 163 | 0.66 | Why? |
| Infectious Disease Transmission, Vertical | 6 | 2021 | 5164 | 0.64 | Why? |
| Pregnancy Trimester, First | 1 | 2018 | 366 | 0.64 | Why? |
| Hypertension, Pregnancy-Induced | 2 | 2021 | 208 | 0.63 | Why? |
| Fetal Growth Retardation | 4 | 2018 | 217 | 0.59 | Why? |
| Diabetes, Gestational | 1 | 2020 | 426 | 0.58 | Why? |
| Diet, Mediterranean | 1 | 2018 | 351 | 0.52 | Why? |
| Obstetrics | 1 | 2020 | 859 | 0.44 | Why? |
| Pregnancy Trimester, Third | 3 | 2021 | 445 | 0.40 | Why? |
| Body Mass Index | 3 | 2020 | 4306 | 0.39 | Why? |
| Patient Care | 1 | 2020 | 1664 | 0.37 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.36 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.36 | Why? |
| Placenta | 2 | 2021 | 1531 | 0.35 | Why? |
| Vascular Resistance | 2 | 2017 | 148 | 0.32 | Why? |
| Feeding Behavior | 1 | 2018 | 1909 | 0.30 | Why? |
| Gestational Age | 4 | 2018 | 1488 | 0.29 | Why? |
| Health Care Rationing | 1 | 2020 | 2558 | 0.29 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.29 | Why? |
| C-Reactive Protein | 1 | 2021 | 7972 | 0.28 | Why? |
| Semen | 1 | 2010 | 550 | 0.27 | Why? |
| Pregnancy Complications | 3 | 2021 | 1388 | 0.26 | Why? |
| Vulvar Neoplasms | 1 | 2003 | 59 | 0.26 | Why? |
| Italy | 9 | 2021 | 38444 | 0.26 | Why? |
| Carcinoma in Situ | 1 | 2003 | 58 | 0.26 | Why? |
| Cesarean Section | 4 | 2021 | 2089 | 0.25 | Why? |
| Infant, Newborn | 9 | 2021 | 23105 | 0.24 | Why? |
| Adrenal Hyperplasia, Congenital | 1 | 2021 | 24 | 0.22 | Why? |
| HIV Seropositivity | 1 | 2003 | 320 | 0.22 | Why? |
| Hepatitis C, Chronic | 1 | 2010 | 973 | 0.21 | Why? |
| Hepacivirus | 1 | 2010 | 1509 | 0.21 | Why? |
| Cardiac Output | 2 | 2018 | 183 | 0.20 | Why? |
| Placenta Diseases | 1 | 2021 | 180 | 0.19 | Why? |
| Term Birth | 1 | 2018 | 56 | 0.19 | Why? |
| Pregnant Women | 3 | 2021 | 2535 | 0.19 | Why? |
| Female | 29 | 2021 | 380317 | 0.19 | Why? |
| B-Cell Activating Factor | 1 | 2018 | 36 | 0.18 | Why? |
| Parity | 1 | 2018 | 122 | 0.18 | Why? |
| Placental Insufficiency | 1 | 2017 | 16 | 0.18 | Why? |
| Cardiac Output, Low | 1 | 2017 | 31 | 0.18 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.17 | Why? |
| Prenatal Diagnosis | 2 | 2018 | 345 | 0.17 | Why? |
| Vagina | 1 | 2020 | 327 | 0.17 | Why? |
| Infant, Small for Gestational Age | 1 | 2017 | 151 | 0.16 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.16 | Why? |
| Adult | 17 | 2021 | 244371 | 0.16 | Why? |
| Fetal Membranes, Premature Rupture | 1 | 2017 | 122 | 0.16 | Why? |
| Pregnancy Outcome | 4 | 2021 | 3803 | 0.15 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.15 | Why? |
| Hospitals, Special | 1 | 2020 | 523 | 0.15 | Why? |
| Papillomavirus Infections | 1 | 2003 | 861 | 0.14 | Why? |
| Premature Birth | 3 | 2021 | 2151 | 0.14 | Why? |
| Perinatal Care | 1 | 2020 | 576 | 0.13 | Why? |
| Ultrasonography, Prenatal | 1 | 2017 | 471 | 0.12 | Why? |
| Heart Rate, Fetal | 3 | 2017 | 38 | 0.12 | Why? |
| Humans | 31 | 2021 | 930598 | 0.12 | Why? |
| Central Nervous System Diseases | 1 | 2017 | 410 | 0.11 | Why? |
| Insulin | 1 | 2020 | 1316 | 0.11 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.11 | Why? |
| Counseling | 1 | 2017 | 747 | 0.11 | Why? |
| Dyspnea | 2 | 2021 | 3847 | 0.11 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.10 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.09 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.09 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.09 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.09 | Why? |
| Hypoglycemic Agents | 1 | 2020 | 2165 | 0.09 | Why? |
| Spermatozoa | 1 | 2010 | 244 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Cough | 1 | 2021 | 4891 | 0.08 | Why? |
| Fever | 2 | 2021 | 7795 | 0.08 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.08 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.08 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.08 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.08 | Why? |
| Referral and Consultation | 1 | 2021 | 4816 | 0.07 | Why? |
| HIV Infections | 1 | 2010 | 11620 | 0.07 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.07 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.06 | Why? |
| Decision Making | 1 | 2017 | 3132 | 0.06 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.05 | Why? |
| Electrocardiography | 1 | 2014 | 3957 | 0.05 | Why? |
| Papillomaviridae | 1 | 2003 | 404 | 0.05 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.05 | Why? |
| Age of Onset | 1 | 2021 | 557 | 0.05 | Why? |
| Delivery Rooms | 1 | 2020 | 148 | 0.05 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2003 | 952 | 0.04 | Why? |
| Cardiotocography | 1 | 2017 | 40 | 0.04 | Why? |
| Uterine Artery | 1 | 2017 | 36 | 0.04 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
| Embryonic and Fetal Development | 2 | 1987 | 3 | 0.04 | Why? |
| Regional Blood Flow | 1 | 2018 | 172 | 0.04 | Why? |
| Pulse Wave Analysis | 1 | 2018 | 221 | 0.04 | Why? |
| Pulsatile Flow | 1 | 2017 | 123 | 0.04 | Why? |
| Tamoxifen | 1 | 1977 | 83 | 0.04 | Why? |
| Middle Cerebral Artery | 1 | 2017 | 128 | 0.04 | Why? |
| Infant, Extremely Premature | 1 | 2017 | 144 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Uterine Contraction | 1 | 2014 | 12 | 0.04 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.04 | Why? |
| Polymerase Chain Reaction | 1 | 2010 | 6740 | 0.04 | Why? |
| Postpartum Period | 1 | 2020 | 936 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2020 | 1265 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Labor, Obstetric | 1 | 2014 | 257 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Breast Feeding | 1 | 2020 | 1585 | 0.02 | Why? |
| Head | 2 | 1987 | 206 | 0.02 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.02 | Why? |
| Male | 3 | 2020 | 367725 | 0.02 | Why? |
| Abdomen | 2 | 1987 | 424 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Fetus | 1 | 1986 | 484 | 0.01 | Why? |
| Breast Neoplasms | 1 | 1977 | 3633 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Middle Aged | 2 | 2020 | 270681 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Menopause | 1 | 1977 | 136 | 0.01 | Why? |
| Neoplasm Metastasis | 1 | 1977 | 682 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Ultrasonography | 2 | 1987 | 4409 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Mathematics | 1 | 1987 | 65 | 0.01 | Why? |
| Parietal Bone | 1 | 1986 | 1 | 0.01 | Why? |
| Anthropometry | 1 | 1987 | 233 | 0.00 | Why? |
| Reference Values | 1 | 1987 | 795 | 0.00 | Why? |
| Analysis of Variance | 1 | 1986 | 950 | 0.00 | Why? |
| Models, Biological | 1 | 1987 | 4907 | 0.00 | Why? |
Ferrazzi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(157)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(210)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_